FinCanna Capital Corp. FNNZF Archives - Page 2 of 3

TuesdayOct 16, 2018 9:40 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Hosting Conference Call, Online Presentation on October 18

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it will hold a conference call and online presentation on Thursday, October 18, 2018 at 4:15pm ET. The FinCanna executive team will lead the call comprised of a presentation, general update and discussion involving information regarding the company’s investee companies from CEO and Director, Andriyko Herchak. FinCanna investee company ezGreen Compliance CEO, Mike Coner, will also provide an update on ezGreen’s latest developments. A question and answer session will follow the presentations. To register for the webcast, visit http://ibn.fm/TRlcO. The…

ThursdayOct 11, 2018 9:36 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company ezGreen Compliance has expanded its proprietary Business Intelligence Dashboard (“BID”) by adding a new comprehensive taxation feature to automate crucial revenue reporting functionality. ezGreen Compliance provides a state-of-the-art enterprise compliance and point-of-sale (“POS”) software solution for licensed medical cannabis dispensaries and cultivators. ezGreen plans to roll out the new taxation feature as a fully integrated component of its BID to the company’s affiliate network comprised of more than 200 dispensary locations. Furthermore, ezGreen’s BID, which was developed…

TuesdayOct 09, 2018 9:27 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Enters Restructured Agreement with Cultivation Technologies Inc.

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has agreed to a restructured agreement (“RA”) with Cultivation Technologies Inc. (“CTI”) due to CTI’s re-focused business strategy towards extraction, manufacturing, and brand development. Per the agreement, CTI will pay FinCanna approximately $3.9 million as repayment of CTI’s outstanding secured loan. FinCanna will also receive payments equal to 3.44% of the consolidated topline revenue of CTI in perpetuity. CTI recently entered into a sale escrow agreement for $4 million for its 6-acre property in Coachella, California which is expected…

WednesdayOct 03, 2018 9:41 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Company Receives $9.6M Purchase Order

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has attained its second purchase order for THC distillate in the minimum amount of $9.6 million, bringing its total purchase orders to $10.4 million. The order was received from a prominent, large volume, California cannabis enterprise and specifies $9.6 million as a minimum annual amount, contingent to consistent delivery and performance. “This multimillion-dollar order from an industry leading distributor illustrates the outstanding reputation and confidence in the Refined Resin team from leading players…

WednesdaySep 26, 2018 9:40 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Company Receives First Purchase Order

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has secured its first purchase order for THC distillate in the amount of $840,000. The purchase order received from a high volume, top California cannabis brand specified $840,000 as the minimum annual amount. Monthly volumes and the related payments may increase based on reliable delivery and performance. “To secure a large purchase order from a top California brand is a testament to the stature of the Refined Resin team and bodes well for…

WednesdaySep 19, 2018 9:26 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Appoints Leading Cannabis Legalization Advocate to Board of Advisors

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Ms. Rosy Mondin, a leading advocate for the legalization of adult use cannabis in Canada, to its Board of Advisors. Mondin co-founded Soma Labs Scientific in 2014, which amalgamated to form Quadron Cannatech Corporation in 2016. Mondin serves as CEO and director Quadron Cannatech Corporation, making her the first woman to hold the role of CEO in a publicly traded company in the cannabis sector. “We are honored to have a woman with Rosy’s in-depth industry knowledge join…

WednesdaySep 12, 2018 9:25 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Posts Letter to Shareholders

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning issued a letter to its shareholders which includes a summary of the year so far and details of the company’s plans for the remainder of 2018. “As you may expect we have a bullish outlook on the industry. We’ve seen very high valuations in publicly listed Canadian cannabis companies and believe the U.S. market is in its infancy with the big gains still to come,” FinCanna Capital president and CEO Andriyko Herchak stated in the news release. “Our share price performance to…

ThursdayAug 30, 2018 11:30 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Names New Board of Directors Member

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Robert “Bob” Kamm to the company’s Board of Directors. Kamm has more than 25 years of experience operating and advising businesses, including his current role representing FinCanna on the Board of Directors of its investee company, Cultivation Technologies Inc. Jeff Tindale has resigned from the FinCanna Board of Directors making way for Kamm’s appointment. Tindale will continue to serve on FinCanna’s Board of Advisors. In addition, the company announced that on August 29, 2018, it issued a total…

WednesdayAug 22, 2018 9:29 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1M Capital Tranche to Refined Resin Technologies

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has advanced the second tranche of capital, $1 million, to its investee company Refined Resin Technologies Inc. Refined Resin is using the series of tranches to implement its three-phase development strategy to operationalize its legally zoned, state-of-the-art medical cannabis extraction laboratory. Presently, Refined Resin has placed deposits and has funds in reserve to purchase all the essential equipment to start production once installed. The extraction facility is anticipated to be in commercial operation by late 2018 or early 2019.…

TuesdayAug 21, 2018 1:54 pm

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Funds Cannabis Companies with Innovative Royalty Financing Model

FinCanna advances $2.25 million to Refined Resin Technologies and ezGreen Compliance California sales account for one-third of U.S. cannabis market California market projected to grow by CAGR of 23 percent to $6.5 billion by 2020 California is now home to the largest legal cannabis market in the world. A pioneer of medical marijuana, which it legalized in 1998, the state has gone a step further by legalizing adult use of marijuana as of January 1, 2018. As a result, sales, already accounting for one-third of legal cannabis sales revenues in the U.S., are projected to reach $4.3 billion in 2018…

Site Search

Company Search

Tag: FinCanna Capital Corp. FNNZF